Nath Bio-Genes (India) jumps after positive Q1 performance

Nath Bio-Genes (India) rose 3% to Rs 379.80 at 14:26 IST on BSE after net profit rose 35.6% to Rs 35.26 crore on a 30.2% surge in net sales to Rs 165.32 crore in Q1 June 2019 over Q1 June 2018.

The result was declared after market hours yesterday, 5 August 2019.

Meanwhile, S&P BSE Sensex was up 506.35 points or 1.38% at 37,206.19.

On BSE, 4,862 shares were traded in Nath Bio-Genes (India) counter, compared to a 2-week average of 4,365 shares. The stock hit an intraday high of Rs 387.50 and an intraday low of Rs 379.80. It hit a 52-week high of Rs 533.05 on 4 September 2018 and a 52-week low of Rs 327.60 on 11 February 2019.

 

EBITDA grew 33.9% to Rs 37.5 crore in Q1 June 2019 over Q1 June 2018. Its EBITDA margin also showed an improvement to 22.7% in Q1 June 2019 as against 21.9% in Q1 June 2018.

Nath Bio-Genes (India) is engaged in hybrid seed business.

Powered by Capital Market - Live News